Fig. 5From: Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trialsComparison of grade 3 or 4 adverse events possibly related to study drug between DP and SP. RR Risk Ratio, CI Confidence Interval, DP mDihydroartemisinin-Piperaquine, SP Sulfadoxine- pyrimethamineBack to article page